Table 3.
CVH Category Prevalence and Potential Impact of Improving CVH Among US Adults
| Subgroups | Proportion of US Adults in CVH Categories, % (95% CI) |
Achievement of Moderate CVH Among US Adults With Low CVH |
Achievement of High CVH Among All US Adults |
||||
|---|---|---|---|---|---|---|---|
| Low | Moderate | High | Population Attributable Fraction, % (95% CI) | CVD Events Prevented, No. in Thousands (95% CI)* | Population Attributable Fraction, % (95% CI) | CVD Events Prevented, No. in Thousands (95% CI) † | |
| Aged 20–39 y | |||||||
| White/other ‡ men | 41.7 (37.7–45.7) | 46.8 (43.6–50.0) | 11.5 (9.2–13.7) | 37.7 (21.9–51.9) | 30 (17–41) | 88.2 (76.1–94.9) | 70 (60–75) |
| Black men | 46.5 (39.9–53.2) | 45.1 (39.8–50.4) | 8.4 (4.0–12.7) | 40.3 (23.8–54.8) | 6 (4–8) | 88.9 (77.3–95.4) | 13 (12–14) |
| White/other ‡ women | 32.4 (28.7–36.1) | 50.0 (46.7–53.2) | 17.6 (14.2–21.1) | 29.7 (12.8–46.0) | 10 (4–16) | 59.4 (33.7–77.0) | 21 (12–27) |
| Black women | 54.7 (47.7–61.7) | 40.0 (33.6–46.3) | 5.3 (2.6–8.1) | 41.7 (20.0–59.6) | 4 (2–6) | 67.8 (42.9–83.2) | 7 (5–9) |
| Total | 38.9 (36.0–41.7) | 47.6 (45.3–49.9) | 13.5 (11.7–15.4) | 36.7 (19.9–51.9) | 51 (28–72) | 80.4 (63.8–90.6) | 112 (89–126) |
| Aged 40–59 y | |||||||
| White/other ‡ men | 65.9 (61.2–70.6) | 29.8 (25.1–34.5) | 4.3 (2.7–5.9) | 51.7 (45.0–57.7) | 232 (202–259) | 75.5 (61.7–85.2) | 340 (277–383) |
| Black men | 81.8 (77.0–86.7) | 17.3 (12.5–22.1) | 0.8 (0.0–1.8) | 57.0 (50.4–62.7) | 45 (40–50) | 78.4 (64.2–87.1) | 62 (51–69) |
| White/other ‡ women | 60.4 (56.4–64.3) | 32.7 (29.3–36.2) | 6.9 (4.9–8.9) | 51.2 (44.7–57.0) | 146 (128–163) | 84.2 (75.5–90.3) | 241 (216–258) |
| Black women | 76.6 (70.7–82.4) | 21.3 (15.7–26.9) | 2.1 (0.8–3.4) | 57.1 (50.5–62.9) | 35 (31–39) | 86.3 (77.9–91.9) | 53 (48–56) |
| Total | 64.9 (61.7–68.1) | 30.0 (27.0–32.9) | 5.2 (3.9–6.4) | 53.1 (46.4–59.1) | 459 (401–511) | 80.4 (68.5–88.7) | 696 (592–767) |
| Aged ≥60 y | |||||||
| White/other ‡ men | 75.7 (72.0–79.5) | 22.3 (18.9–25.8) | 1.9 (0.9–3.0) | 38.8 (32.5–44.5) | 355 (298–408) | 62.1 (46.2–73.8) | 569 (424–676) |
| Black men | 81.9 (76.6–87.2) | 17.0 (12.0–21.9) | 1.1 (0.0–2.3) | 40.6 (34.2–46.5) | 25 (21–29) | 63.3 (47.2–75.1) | 39 (29–46) |
| White/other ‡ women | 75.0 (70.5–79.5) | 23.1 (18.6–27.5) | 1.9 (0.9–3.0) | 35.7 (29.8–41.2) | 285 (238–330) | 67.9 (55.8–77.1) | 543 (446–617) |
| Black women | 89.8 (87.0–92.7) | 9.5 (6.6–12.4) | 0.7 (0.0–1.3) | 39.9 (34.0–45.5) | 22 (19–25) | 70.1 (57.5–79.3) | 39 (32–44) |
| Total | 76.3 (73.1–79.4) | 21.9 (18.9–24.8) | 1.8 (1.2–2.5) | 37.2 (31.2–42.9) | 688 (577–791) | 64.4 (50.4–74.9) | 1189 (931–1383) |
| Men | 60.3 (57.7–62.9) | 33.6 (31.3–35.9) | 6.1 (5.1–7.1) | 43.8 (36.8–50.2) | 694 (583–795) | 69.0 (53.9–79.9) | 1093 (854–1265) |
| Women | 56.9 (54.0–59.8) | 34.7 (32.4–37.0) | 8.4 (6.7–10.1) | 39.8 (33.4–45.7) | 504 (423–579) | 71.3 (59.9–79.9) | 903 (758–1011) |
| White/other ‡ adults | 57.2 (54.6–59.8) | 35.0 (33.1–37.0) | 7.8 (6.6–8.9) | 41.4 (34.7–47.6) | 1060 (889–1217) | 69.7 (56.1–79.6) | 1783 (1436–2037) |
| Black adults | 69.0 (66.0–71.9) | 27.5 (24.8–30.1) | 3.5 (2.3–4.8) | 47.4 (40.0–53.8) | 138 (117–157) | 73.4 (60.4–82.0) | 214 (176–239) |
| All adults | 58.5 (56.1–60.9) | 34.2 (32.4–36.0) | 7.3 (6.3–8.3) | 42.0 (35.3–48.2) | 1198 (1005–1374) | 70.0 (56.5–79.9) | 1996 (1611–2276) |
CVD indicates cardiovascular disease; and CVH, cardiovascular health.
* Number of CVD events prevented annually if (1) all adults with low CVH had moderate CVH; and (2) all adults with moderate CVH or high CVH remained in these groups.
† Number of CVD events prevented annually if all adults with low CVH or moderate CVH had high CVH.
‡Includes Mexican American, other Hispanic, non‐Hispanic Asian, and other races.